These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15895904)

  • 1. Lupus erythematosus manifestations exacerbated by etanercept therapy in a patient with mixed connective tissue disease.
    Richez C; Blanco P; Dumoulin C; Schaeverbeke T
    Clin Exp Rheumatol; 2005; 23(2):273. PubMed ID: 15895904
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue disease.
    Christopher-Stine L; Wigley F
    J Rheumatol; 2003 Dec; 30(12):2725-7. PubMed ID: 14719225
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoimmune Pitfalls of Anti-Tumor Necrosis Factor-Alpha Therapy.
    Roginić S; Jelić A; Stipić-Marković A; Marinko A; Artuković IN; Dušanka MK
    Isr Med Assoc J; 2015 Feb; 17(2):117-9. PubMed ID: 26223091
    [No Abstract]   [Full Text] [Related]  

  • 4. Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis.
    Carlson E; Rothfield N
    Arthritis Rheum; 2003 Apr; 48(4):1165-6; author reply 1166. PubMed ID: 12687569
    [No Abstract]   [Full Text] [Related]  

  • 5. New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis.
    Cairns AP; Duncan MK; Hinder AE; Taggart AJ
    Ann Rheum Dis; 2002 Nov; 61(11):1031-2. PubMed ID: 12379532
    [No Abstract]   [Full Text] [Related]  

  • 6. Etanercept-induced lupus erythematosus presenting as a unilateral pleural effusion.
    Abunasser J; Forouhar FA; Metersky ML
    Chest; 2008 Oct; 134(4):850-853. PubMed ID: 18842918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced systemic lupus erythematosus associated with etanercept therapy.
    Shakoor N; Michalska M; Harris CA; Block JA
    Lancet; 2002 Feb; 359(9306):579-80. PubMed ID: 11867114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
    De Bandt M; Sibilia J; Le Loët X; Prouzeau S; Fautrel B; Marcelli C; Boucquillard E; Siame JL; Mariette X;
    Arthritis Res Ther; 2005; 7(3):R545-51. PubMed ID: 15899041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
    Williams VL; Cohen PR
    Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept.
    Mor A; Bingham CO; Barisoni L; Lydon E; Belmont HM
    J Rheumatol; 2005 Apr; 32(4):740-3. PubMed ID: 15801034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful etanercept therapy for refractory sacroiliitis in a patient with ankylosing spondylitis and mixed connective tissue disease.
    Lee JY; Chang HK; Kim SK
    Yonsei Med J; 2008 Feb; 49(1):159-62. PubMed ID: 18306484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced lupus due to anti-tumor necrosis factor alpha agents.
    Costa MF; Said NR; Zimmermann B
    Semin Arthritis Rheum; 2008 Jun; 37(6):381-7. PubMed ID: 17977585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept-induced systemic lupus erythematosus.
    Swale VJ; Perrett CM; Denton CP; Black CM; Rustin MH
    Clin Exp Dermatol; 2003 Nov; 28(6):604-7. PubMed ID: 14616825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept-associated SLE with lupus nephritis.
    Neradová A; Stam F; van den Berg JG; Bax WA
    Lupus; 2009 Jun; 18(7):667-8. PubMed ID: 19433471
    [No Abstract]   [Full Text] [Related]  

  • 16. Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
    Kang MJ; Lee YH; Lee J
    J Korean Med Sci; 2006 Oct; 21(5):946-9. PubMed ID: 17043436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
    de Vlam K; Lories RJ
    Rheumatology (Oxford); 2006 Mar; 45(3):321-4. PubMed ID: 16234275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].
    Haake H; Köneke J; Amann K; vom Dahl J; Janssen U
    Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TNF-alpha-induced systemic lupus syndrome.
    Debandt M; Vittecoq O; Descamps V; Le Loët X; Meyer O
    Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Crohn's disease in a patient taking etanercept.
    Oh J; Arkfeld DG; Horwitz DA
    J Rheumatol; 2005 Apr; 32(4):752-3. PubMed ID: 15801037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.